| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 22 | 2022 | 98 | 6.830 |
Why?
|
| Astrocytes | 29 | 2022 | 270 | 6.130 |
Why?
|
| Motor Neurons | 22 | 2022 | 98 | 3.460 |
Why?
|
| Superoxide Dismutase-1 | 14 | 2022 | 41 | 3.420 |
Why?
|
| Superoxide Dismutase | 17 | 2022 | 149 | 2.930 |
Why?
|
| NF-E2-Related Factor 2 | 13 | 2021 | 110 | 2.130 |
Why?
|
| NAD | 3 | 2020 | 73 | 1.810 |
Why?
|
| Neurons | 10 | 2018 | 881 | 1.510 |
Why?
|
| Spinal Cord | 11 | 2020 | 244 | 1.420 |
Why?
|
| Glutathione | 7 | 2018 | 343 | 1.370 |
Why?
|
| Sirtuins | 3 | 2021 | 16 | 1.070 |
Why?
|
| Mice, Transgenic | 16 | 2022 | 1032 | 1.050 |
Why?
|
| Cells, Cultured | 20 | 2021 | 2673 | 1.010 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 1293 | 0.930 |
Why?
|
| Animals | 40 | 2022 | 20877 | 0.920 |
Why?
|
| Mice | 23 | 2022 | 8472 | 0.910 |
Why?
|
| Disease Models, Animal | 15 | 2022 | 2550 | 0.840 |
Why?
|
| CLOCK Proteins | 1 | 2021 | 7 | 0.790 |
Why?
|
| Nerve Growth Factor | 10 | 2017 | 54 | 0.740 |
Why?
|
| Biosynthetic Pathways | 1 | 2020 | 15 | 0.730 |
Why?
|
| Neurodegenerative Diseases | 3 | 2017 | 102 | 0.720 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2019 | 3 | 0.700 |
Why?
|
| Mitochondria | 4 | 2014 | 643 | 0.690 |
Why?
|
| Niacinamide | 1 | 2019 | 31 | 0.690 |
Why?
|
| Central Nervous System | 2 | 2018 | 107 | 0.640 |
Why?
|
| Motor Neuron Disease | 1 | 2018 | 10 | 0.640 |
Why?
|
| Nerve Degeneration | 5 | 2018 | 134 | 0.640 |
Why?
|
| Receptor, Nerve Growth Factor | 6 | 2017 | 19 | 0.620 |
Why?
|
| Cell Communication | 5 | 2010 | 116 | 0.560 |
Why?
|
| Mutation, Missense | 1 | 2016 | 112 | 0.530 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 181 | 0.510 |
Why?
|
| Catalase | 1 | 2014 | 85 | 0.490 |
Why?
|
| Proteomics | 1 | 2015 | 246 | 0.460 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2013 | 5 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 2790 | 0.430 |
Why?
|
| Fibroblast Growth Factor 1 | 4 | 2006 | 13 | 0.420 |
Why?
|
| Aging | 1 | 2018 | 911 | 0.420 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 2 | 2021 | 5 | 0.390 |
Why?
|
| Oxidative Stress | 5 | 2018 | 718 | 0.370 |
Why?
|
| Signal Transduction | 4 | 2018 | 2688 | 0.360 |
Why?
|
| Mice, Knockout | 5 | 2020 | 1692 | 0.350 |
Why?
|
| Cytoprotection | 1 | 2009 | 39 | 0.350 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2013 | 710 | 0.350 |
Why?
|
| Up-Regulation | 4 | 2020 | 682 | 0.350 |
Why?
|
| Receptor for Advanced Glycation End Products | 2 | 2020 | 19 | 0.340 |
Why?
|
| Peroxynitrous Acid | 3 | 2006 | 55 | 0.320 |
Why?
|
| Phenotype | 2 | 2022 | 946 | 0.320 |
Why?
|
| Humans | 23 | 2021 | 68525 | 0.320 |
Why?
|
| Glutamate-Cysteine Ligase | 2 | 2018 | 16 | 0.300 |
Why?
|
| Reactive Oxygen Species | 4 | 2015 | 499 | 0.290 |
Why?
|
| Coculture Techniques | 5 | 2011 | 147 | 0.290 |
Why?
|
| Mutation | 3 | 2019 | 1213 | 0.280 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 11 | 0.270 |
Why?
|
| Proteins | 1 | 2009 | 473 | 0.270 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2018 | 92 | 0.260 |
Why?
|
| Rats | 14 | 2012 | 5300 | 0.260 |
Why?
|
| Antioxidants | 3 | 2016 | 304 | 0.250 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 48 | 0.240 |
Why?
|
| Trans-Activators | 1 | 2005 | 237 | 0.240 |
Why?
|
| Gliosis | 5 | 2017 | 51 | 0.230 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2004 | 124 | 0.220 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2022 | 3 | 0.220 |
Why?
|
| Cell Survival | 5 | 2012 | 901 | 0.210 |
Why?
|
| Apoptosis | 5 | 2007 | 1640 | 0.200 |
Why?
|
| Antioxidant Response Elements | 2 | 2019 | 10 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2012 | 2083 | 0.200 |
Why?
|
| Phosphogluconate Dehydrogenase | 1 | 2021 | 2 | 0.200 |
Why?
|
| Phosphofructokinase-2 | 1 | 2021 | 4 | 0.200 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 5 | 0.200 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2021 | 10 | 0.200 |
Why?
|
| Animals, Newborn | 7 | 2006 | 396 | 0.200 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 700 | 0.200 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 2020 | 6 | 0.190 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 396 | 0.190 |
Why?
|
| Down-Regulation | 1 | 2022 | 447 | 0.190 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2020 | 5 | 0.190 |
Why?
|
| Sirtuin 3 | 1 | 2020 | 6 | 0.180 |
Why?
|
| Nitric Oxide | 4 | 2016 | 382 | 0.180 |
Why?
|
| Animals, Genetically Modified | 3 | 2008 | 63 | 0.170 |
Why?
|
| Pyridinium Compounds | 1 | 2019 | 40 | 0.170 |
Why?
|
| Cell Death | 3 | 2016 | 329 | 0.160 |
Why?
|
| Galectin 3 | 1 | 2018 | 8 | 0.160 |
Why?
|
| Blotting, Western | 4 | 2008 | 954 | 0.160 |
Why?
|
| Receptors, Nerve Growth Factor | 3 | 2006 | 20 | 0.150 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 567 | 0.140 |
Why?
|
| Cytokines | 1 | 2021 | 866 | 0.140 |
Why?
|
| Tyrosine | 3 | 2012 | 196 | 0.140 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 137 | 0.140 |
Why?
|
| Acetylation | 1 | 2015 | 94 | 0.130 |
Why?
|
| Inflammation | 1 | 2022 | 1030 | 0.130 |
Why?
|
| Lysine | 1 | 2015 | 96 | 0.130 |
Why?
|
| tau Proteins | 2 | 2006 | 61 | 0.130 |
Why?
|
| Gene Expression | 3 | 2013 | 770 | 0.130 |
Why?
|
| RNA, Messenger | 4 | 2010 | 1663 | 0.120 |
Why?
|
| Time Factors | 4 | 2013 | 4655 | 0.120 |
Why?
|
| Embryo, Mammalian | 4 | 2007 | 176 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 284 | 0.120 |
Why?
|
| alpha-Synuclein | 1 | 2012 | 28 | 0.110 |
Why?
|
| Hippocampus | 2 | 2006 | 471 | 0.100 |
Why?
|
| Cell Count | 3 | 2006 | 248 | 0.100 |
Why?
|
| Drug Interactions | 3 | 2006 | 289 | 0.100 |
Why?
|
| Alanine | 1 | 2011 | 38 | 0.100 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 134 | 0.100 |
Why?
|
| Corpus Striatum | 2 | 2010 | 278 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2013 | 714 | 0.100 |
Why?
|
| Receptors, Death Domain | 1 | 2010 | 1 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2008 | 282 | 0.100 |
Why?
|
| Glycine | 1 | 2011 | 89 | 0.100 |
Why?
|
| Succinate Dehydrogenase | 1 | 2010 | 13 | 0.090 |
Why?
|
| Parkinson Disease | 2 | 2012 | 272 | 0.090 |
Why?
|
| Lead | 1 | 2009 | 45 | 0.090 |
Why?
|
| Major Histocompatibility Complex | 1 | 2009 | 34 | 0.090 |
Why?
|
| MPTP Poisoning | 1 | 2009 | 10 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 1174 | 0.090 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2008 | 3 | 0.090 |
Why?
|
| Decorin | 1 | 2008 | 8 | 0.090 |
Why?
|
| Urea | 2 | 2006 | 51 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2008 | 42 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 2009 | 168 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 196 | 0.080 |
Why?
|
| Vesicular Transport Proteins | 1 | 2009 | 87 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 219 | 0.080 |
Why?
|
| Proteoglycans | 1 | 2008 | 103 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 144 | 0.080 |
Why?
|
| Pyrimidines | 2 | 2006 | 178 | 0.080 |
Why?
|
| Heart | 1 | 2012 | 850 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2007 | 791 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 320 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 434 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 215 | 0.070 |
Why?
|
| Reactive Nitrogen Species | 1 | 2006 | 32 | 0.070 |
Why?
|
| Methionine | 1 | 2006 | 36 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 498 | 0.070 |
Why?
|
| Propionates | 1 | 2006 | 21 | 0.070 |
Why?
|
| Hydroquinones | 1 | 2006 | 15 | 0.070 |
Why?
|
| Nerve Growth Factors | 1 | 2006 | 75 | 0.070 |
Why?
|
| Nitrites | 1 | 2006 | 53 | 0.070 |
Why?
|
| Nitrates | 1 | 2006 | 61 | 0.070 |
Why?
|
| Quinolines | 1 | 2006 | 48 | 0.070 |
Why?
|
| Kinetics | 2 | 2004 | 1047 | 0.070 |
Why?
|
| Rats, Mutant Strains | 1 | 2005 | 14 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 201 | 0.070 |
Why?
|
| Heme Oxygenase-1 | 1 | 2005 | 40 | 0.070 |
Why?
|
| RNA, Antisense | 1 | 2005 | 25 | 0.060 |
Why?
|
| Transfection | 1 | 2006 | 782 | 0.060 |
Why?
|
| Hypoxia | 1 | 2005 | 169 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 282 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 307 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2012 | 1199 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2005 | 617 | 0.050 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 659 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 1745 | 0.040 |
Why?
|
| Female | 4 | 2020 | 38015 | 0.040 |
Why?
|
| Male | 3 | 2020 | 37281 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 1037 | 0.040 |
Why?
|
| DNA Primers | 2 | 2009 | 302 | 0.040 |
Why?
|
| Oleic Acid | 1 | 2016 | 40 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2016 | 86 | 0.040 |
Why?
|
| Models, Animal | 2 | 2008 | 252 | 0.030 |
Why?
|
| Culture Media, Conditioned | 2 | 2006 | 78 | 0.030 |
Why?
|
| Base Sequence | 2 | 2009 | 1015 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 226 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2016 | 222 | 0.030 |
Why?
|
| Autophagy | 1 | 2012 | 207 | 0.020 |
Why?
|
| Malonates | 1 | 2010 | 4 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2010 | 22 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2009 | 24 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 317 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2009 | 46 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2009 | 22 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 71 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2009 | 102 | 0.020 |
Why?
|
| Stem Cells | 1 | 2010 | 248 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2007 | 16 | 0.020 |
Why?
|
| Nitroso Compounds | 1 | 2007 | 16 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2007 | 75 | 0.020 |
Why?
|
| Nitric Oxide Donors | 1 | 2007 | 54 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 1055 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 2331 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2006 | 48 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 60 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2006 | 52 | 0.020 |
Why?
|
| Caffeine | 1 | 2006 | 81 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2009 | 384 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 322 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1034 | 0.020 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2007 | 183 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 284 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2005 | 11 | 0.020 |
Why?
|
| Metalloporphyrins | 1 | 2005 | 25 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2006 | 190 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 201 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 100 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 230 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2005 | 251 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2004 | 23 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2005 | 112 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2004 | 21 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2005 | 233 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 195 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2005 | 113 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 455 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2006 | 483 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1039 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 216 | 0.010 |
Why?
|
| Antibodies | 1 | 2004 | 241 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 244 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1082 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 1446 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2004 | 332 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 1860 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2004 | 563 | 0.010 |
Why?
|